Science

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

nottingham.ac.uk

Jan 15, 2025, 13:40

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X about a recent paper by John Robertson, Professor of Surgery of the Faculty of Medicine and Health Sciences at the University of Nottingham, published in Journal of Clinical Oncology:

“Fulvestrant Versus Anastrozole in Endocrine Therapy – Naïve Women With Hormone Receptor – Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Prespecified final OS analysis from FALCON and updated safety information.”

“Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial”

Authors: John Robertson, Zhimin Shao, Shinzaburo Noguchi, Igor Bondarenko, Lawrence Panasci, Sandeep Singh, Shankar Subramaniam, Matthew Ellis.

Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.

More posts featuring Elisabetta Bonzano.

Breast Cancer cancer Elisabetta Bonzano FALCON Igor Bondarenko John Robertson Lawrence Panasci Matthew Ellis OncoDaily Oncology Sandeep Singh Shankar Subramaniam Shinzaburo Noguchi Zhimin Shao

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer